Event Participants
Executives
2 M. R. Jyothy, Pawan Kumar Agarwal
Analysts
8 Aniket Kamble, Darshit Vora, Lokesh Kumar, Nitin Shakdher, Percy Panthaki, Ronak Shah, Rushabh Shah, Sonal Minhas, Vishal Gutka
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue Growth (ex-Prill & Fa) | 8.1% value, 5.3% volume YoY | Growth driven by Fabritare; muted by price increases and competitive SKU-level actions |
| Gross Margin | 38.5%, -950 bps YoY | Abnormally high input cost inflation (crude-linked), lower realizations; no benefit of lower-cost inventory |
| EBITDA Margin | 8.4%, -820 bps YoY | Flow-through of gross margin contraction; A&P spend moderated to 6.5% of revenue |
| Employee Cost | 11.4% of revenue | Flat vs 11.5% YoY |
| A&P Spend | 6.5% of revenue | Down from 7.8% YoY; management intends to step up investments going forward |
| Other Expenses | 12.0% of revenue | Slightly lower vs 12.1% YoY |
| Net Cash | ~₹850 crores | Strong balance sheet; available for M&A and strategic investments |
Geographic & Segment Commentary
Fabric Care: Strong momentum with over 14% value growth and 10% volume growth. Detergent powders and bars grew in double digits; liquid detergents continued high-growth trajectory across Henko, Ujala, Mr. White, and Morelite. Segment price increases were ~5% on a portfolio basis.
Home Care: Grew 2.4% YoY excluding Pril sales; dishwash portfolio impacted by Pril exit (effective 31 May 2026). Newly launched bioenzyme-based EXO Liquid showed encouraging early progress; broader EXO franchise grew mid-to-high single digit in value and double digit in volume. Household insecticides affected by extended summer and delayed rainfall; Maxo Incense Sticks launched in July.
Personal Care: Performance remained subdued due to price increases (~9-10%) and transient supply chain disruptions. Management expects recovery from Q2 onwards. Soap noodle prices increased from June, with monitoring underway for sustained inflation.
Company-Specific & Strategic Commentary
Segment Reporting Restructure: Aligned to IndAS 108, now reporting under 3 segments (Fabric Care, Home Care, Personal Care) for clearer investor view of business management and capital allocation.
EXO Liquid Launch: New bioenzyme-based dishwash liquid launched 3-4 months ago; early performance in line with expectations. Represents strategic response to Pril exit and competitive market dynamics.
Maxo Incense Sticks: Launched July 2026 to address unsafe local agarbattis; government-approved, priced at par with competition. Positioned as second organized player with differentiated molecule and faster action (2 minutes).
Crude Dependency Management: Company working on reducing dependence on crude-linked raw materials over last 1.5 years; focusing on diversification, value engineering, and alternative ingredients (including bio-based surfactants) to reduce future margin volatility.
M&A Activity: Evaluated TTK business but declined due to strategic misalignment (2 of 4 divisions not aligned, significant overlap in remaining 2). Continuing aggressive evaluation of assets with stringent filters aligned to growth strategy.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Revenue Growth (FY27, ex-Prill & Fa) | Double-digit value growth | Supported by ~3-4% price increases, high single-digit volume growth; momentum expected to continue across segments |
| Volume Growth (FY27) | High single digit | Balanced across segments; Fabric Care momentum, Personal Care recovery from Q2, EXO scaling |
| EBITDA Margin (FY27) | Under pressure; H2 substantially better than H1 | Recovery progressive, linked to crude price stability and top-line growth; historical margin levels target subject to external conditions |
| Price Increases | ~4-4.5% total, 3% flowed through Q1 | Blended; ~9-10% in Personal Care, ~4-5% in other segments; SKU-level competitive actions limiting uptake |
| Margin Recovery Timing | Gradual; meaningful benefit from October | Higher-cost inventories flowing through Q2; commodity stability required for sustained recovery |
Risks & Constraints
| Risk | Context |
|---|---|
| Crude Oil Price Volatility | ~90% of business linked to crude-linked inputs; West Asia conflict caused 30-35% input cost spike. Recent moderation encouraging but lagged impact continues through Q2. Management working to diversify raw material base over last 1.5 years. |
| Competitive Pricing Pressure | Competition reducing prices on SKU-level basis, particularly in dishwash and detergent categories; limits ability to fully pass on cost inflation. Management matched at par with competition to protect market share. |
| Urban Demand Weakness | Urban consumption remained subdued; GT growth muted due to lower urban demand. Cautious consumer sentiment affecting discretionary spending; recovery dependent on demand momentum. |
| Pril Exit Residual Impact | Pril exit effective 31 May 2026 created revenue gap; matter before court with no clarity on cooling-off period. EXO Liquid scaling up but still early stage. |
| Soap Noodle Inflation | Key personal care raw material witnessing price increases from June; potential sustained inflationary cycle could pressure segment margins. |
Q&A Highlights
Pricing Strategy & Inflation Recovery
Question: Total price increases taken since the start of the war, and why lower than peers? (Percy Panthaki, IIFL)
Answer: Total ~4-4.5%, with 3% flowed through Q1, rest in Q2. Blended across portfolio; Personal Care at 9-10%, other segments 4-5%. SKU-level competitive actions limited pricing; company at par with competition on most brands. Fabric Care ~5% pricing but dishwash was competitive. (Pawan Agarwal, M. R. Jyothy)
Question: Is Q2 the bottom for margins, or can we see more pressure? (Ronak Shah, Equirus)
Answer: Sharp Q1 contraction driven by raw material inflation flowing through while pricing catches up. Recent crude trends encouraging but benefit comes with lag due to inventory cycles. Cannot confirm bottom, but "not going to be materially lower than Q1" and working to improve margins progressively. (Pawan Agarwal)
Premiumization Context & Portfolio Gaps
- Question: Why did you say premium brands have few takers in India? And product portfolio gaps in premium segment? (Rushabh Shah, Buglerock PMS)
- Answer: Context was that even premium products operate at heavy discounts in current low-consumption environment; premiumization taking a hit with discounting and cheap product introductions. Majority of India still driven by lower prices. Henko is premium; EXO operates at top end of price ladder in dishwash with premium 500g bar SKU. Liquid detergents now priced below powders due to competition. (M. R. Jyothy)
Working Capital Management
- Question: How sustainable is working capital improvement and what are you doing differently? (Rushabh Shah, Buglerock PMS)
- Answer: Focus on business hygiene; significant portion of GT business on advance payment basis. MT/E-commerce/Q-commerce terms comparable. Distributor stock maintained at 15-20 days. These fundamental levers drive working capital efficiency. (Pawan Agarwal)
Pril Exit, Maxo Launch, and M&A
- Question: Cooling-off period for Pril? Maxo pricing strategy? TTK-Wipro deal evaluation? (Vishal Gutka, ASK Investment Managers)
- Answer: No specific clause requiring Henkel to wait; matter before court, cannot comment further. Maxo priced at par with competition; second organized player entering growing category. TTK evaluated but 2 divisions not aligned to strategy, significant overlap in remaining 2—did not pursue. Continuously looking at assets with stringent filters. (Pawan Agarwal, M. R. Jyothy)
Revenue Growth Trajectory & Double-Digit Aspiration
- Question: By when should we expect double-digit revenue growth given Pril exit and pricing balance? (Vishal Gutka, ASK Investment Managers)
- Answer: Endeavor is to deliver double-digit ex-Prill/Fa from current quarter; 3-4% price increase plus high single-digit volume growth. FY27 ex-Prill/Fa double-digit growth expected with all three segments contributing. (Pawan Agarwal)
Channel Performance
- Question: Is GT degrowing ex-Prill/Fa? What's the competitive positioning in quick commerce? (Sonal Minhas, Prescient Capital)
- Answer: GT ex-Prill/Fa on positive side but under pressure from urban demand. E-commerce and quick commerce growing 25-30%, among fastest growing channels. No material gaps vs competitors; focus on channel-specific assortment, premium packs, and visibility. (Pawan Agarwal)
Crude Dependency & Structural Margin Concerns
- Question: Is the margin decline structural given 10% gross margin drop? How confident are you of returning to 18-20% EBITDA? (Lokesh Kumar, Individual Investor)
- Answer: Not a commodity business; input price increase of 30-35% unprecedented in company history. Raw material impact ~15-16% offset by 3% price increase and 3-4% efficiencies. Working on diversifying crude dependence for 1.5 years; scaling innovations gives confidence of recovery once crude cools. Competition behaves like commodity by reducing prices when we launch; pricing must balance consumer affordability. (Pawan Agarwal, M. R. Jyothy)
Alternative Ingredients & R&D Direction
- Question: Can you develop products less dependent on crude derivatives, using bio-based ingredients? Any new category development? (Nitin Shakdher, Green Capital)
- Answer: Working on diversification and bio-based alternatives; "big lesson learned" from current cycle with multiple projects underway. New product development across categories in progress; announcements expected in future. (M. R. Jyothy)
Maxo Incense Sticks Differentiation
- Question: How is Maxo better than competition and how are you communicating this? (Darshit Vora, Asit C. Mehta)
- Answer: Trusted, stable molecule with lab results showing superiority; government-approved; acts in 2 minutes. Communication will begin as distribution expands. (M. R. Jyothy)
Key Takeaway
Jyothy Laboratories reported a challenging Q1 FY27 with EBITDA margins contracting 820 bps YoY to 8.4%, driven by unprecedented 30-35% crude-linked input cost inflation against which only ~3% pricing flowed through. Revenue grew 8.1% value/5.3% volume (ex-Prill & Fa), led by Fabric Care's 14% growth, while Home Care and Personal Care remained subdued. Management maintains FY27 double-digit revenue guidance ex-Prill/Fa with high single-digit volumes, positioning margin recovery as progressive and H2-weighted, contingent on crude stability. Strategic priorities include scaling EXO Liquid post-Prill exit, launching Maxo Incense Sticks into the ₹4,000 crore household insecticides market, reducing crude dependency through R&D diversification, and aggressively evaluating M&A with ₹850 crores net cash. Key watch points include competitive SKU-level pricing pressure limiting pass-through, urban demand recovery, and sustainability of input cost deflation into Q3 FY27.